Update: 20.02.2023
Last week: 6 week 2023 (06.02.2023 - 12.02.2023)
Last full month: January 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 99 622 | -4.3% | 2.8% | 0.1 | 27 394 018 | -4.2% | 3.4% | 0.1 | -6.7% |
| MoM | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| YTD | 672 700 | -69.9% | 2.8% | -3.4 | 182 605 772 | -57.1% | 3.5% | -2.5 | -33.7% |
| MAT | 8 280 696 | -43.2% | 4.3% | -2.3 | 1 777 112 518 | -30.5% | 4.3% | -1.7 | -12.9% |
| DEXALGIN | |||||||||
| WoW | 14 445 | -8.2% | 0.3% | 0 | 7 974 846 | -5.6% | 1.1% | 0 | -5.9% |
| MoM | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| YTD | 108 673 | -60.0% | 0.4% | -0.4 | 58 028 809 | -45.0% | 1.3% | -0.9 | -21.1% |
| MAT | 1 422 818 | -25.5% | 0.6% | -0.1 | 639 187 720 | -12.5% | 1.6% | -0.4 | -5.6% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 49 235 | -3.2% | 38.6% | 0 | 31 401 775 | -3.1% | 48.7% | 0.4 | -3.2% |
| MoM | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| YTD | 305 622 | -54.3% | 39.2% | -22.1 | 197 493 364 | -37.8% | 49.9% | -18 | -28.5% |
| MAT | 3 921 211 | -26.5% | 50.5% | -14.6 | 2 088 607 382 | -15.7% | 56.7% | -13.2 | -5.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 19 726 | -4.5% | 30.0% | 0.1 | 15 520 372 | -3.6% | 47.7% | 0.5 | -4.9% |
| MoM | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| YTD | 121 027 | -38.8% | 29.8% | -9.7 | 94 606 093 | -18.4% | 47.0% | -6.9 | -18.8% |
| MAT | 1 349 362 | -18.1% | 35.8% | -5.1 | 884 244 799 | -8.4% | 49.5% | -6.1 | -6.3% |
| FASTUM | |||||||||
| WoW | 12 905 | -5.0% | 0.8% | 0 | 7 867 163 | -3.5% | 2.2% | 0 | -4.0% |
| MoM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| YTD | 88 691 | -48.8% | 0.9% | -0.6 | 54 379 683 | -32.8% | 2.5% | -0.8 | -15.9% |
| MAT | 955 883 | -30.9% | 1.0% | -0.4 | 519 793 557 | -19.1% | 2.4% | -0.7 | -2.6% |
| IODOMARIN | |||||||||
| WoW | 64 655 | -2.1% | 22.3% | -0.2 | 12 122 775 | -1.5% | 9.0% | -0.2 | -1.3% |
| MoM | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| YTD | 361 199 | -20.0% | 21.3% | -1.3 | 67 056 078 | -19.1% | 8.3% | -1.7 | -15.3% |
| MAT | 3 202 865 | -2.8% | 20.4% | -0.7 | 624 189 623 | 2.0% | 8.9% | -0.6 | 0.6% |
| LIOTON | |||||||||
| WoW | 15 499 | -15.7% | 1.8% | -0.3 | 19 438 048 | -15.7% | 4.7% | -0.6 | -3.1% |
| MoM | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| YTD | 86 376 | -46.9% | 1.7% | -0.8 | 107 442 053 | -24.8% | 4.3% | -1 | -20.2% |
| MAT | 1 175 164 | -30.6% | 2.1% | -0.6 | 1 272 024 499 | -10.4% | 4.5% | -1.1 | -9.8% |
| MEZYM | |||||||||
| WoW | 189 325 | -4.3% | 19.1% | 0 | 30 087 867 | -3.6% | 13.0% | -0.1 | -4.3% |
| MoM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| YTD | 1 292 183 | -55.6% | 19.4% | -11.5 | 201 869 954 | -51.0% | 13.3% | -9.8 | -29.1% |
| MAT | 15 735 161 | -26.3% | 24.0% | -5.5 | 2 433 933 092 | -18.9% | 17.0% | -5.1 | -9.3% |
| MIG 400 | |||||||||
| WoW | 91 671 | -6.0% | 2.1% | 0 | 11 257 964 | -5.1% | 1.6% | 0 | -5.9% |
| MoM | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| YTD | 633 270 | -45.7% | 2.2% | -1 | 80 136 531 | -40.1% | 1.8% | -0.9 | -21.1% |
| MAT | 7 863 698 | -23.5% | 3.1% | -0.7 | 940 482 545 | -19.2% | 2.3% | -0.8 | -5.6% |
| PROSTAMOL | |||||||||
| WoW | 18 749 | -4.5% | 12.4% | -0.2 | 28 674 527 | -3.8% | 14.1% | -0.3 | -3.2% |
| MoM | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| YTD | 121 942 | -52.6% | 13.4% | -9.8 | 183 826 345 | -45.5% | 15.3% | -9.4 | -18.0% |
| MAT | 1 411 291 | -33.4% | 16.9% | -7.4 | 2 011 338 453 | -25.4% | 18.2% | -8.1 | -4.3% |
| RESPERO MYRTOL | |||||||||
| WoW | 22 256 | -7.6% | 6.8% | -0.5 | 13 024 566 | -6.9% | 8.2% | -0.6 | -1.2% |
| MoM | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
| YTD | 138 537 | -43.1% | 7.2% | -3 | 79 298 050 | -25.9% | 8.4% | -1.4 | -19.3% |
| MAT | 1 196 419 | 23.6% | 7.9% | 1.6 | 595 904 283 | 35.2% | 8.3% | 1.8 | -1.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 672 700 | -69.9% | 2.8% | -3.4 | 182 605 772 | -57.1% | 3.5% | -2.5 | -33.7% |
| DEXALGIN | 108 673 | -60.0% | 0.4% | -0.4 | 58 028 809 | -45.0% | 1.3% | -0.9 | -21.1% |
| ESPUMISAN (ADULTS) | 305 622 | -54.3% | 39.2% | -22.1 | 197 493 364 | -37.8% | 49.9% | -18 | -28.5% |
| ESPUMISAN BABY | 121 027 | -38.8% | 29.8% | -9.7 | 94 606 093 | -18.4% | 47.0% | -6.9 | -18.8% |
| FASTUM | 88 691 | -48.8% | 0.9% | -0.6 | 54 379 683 | -32.8% | 2.5% | -0.8 | -15.9% |
| IODOMARIN | 361 199 | -20.0% | 21.3% | -1.3 | 67 056 078 | -19.1% | 8.3% | -1.7 | -15.3% |
| LIOTON | 86 376 | -46.9% | 1.7% | -0.8 | 107 442 053 | -24.8% | 4.3% | -1 | -20.2% |
| MEZYM | 1 292 183 | -55.6% | 19.4% | -11.5 | 201 869 954 | -51.0% | 13.3% | -9.8 | -29.1% |
| MIG 400 | 633 270 | -45.7% | 2.2% | -1 | 80 136 531 | -40.1% | 1.8% | -0.9 | -21.1% |
| PROSTAMOL | 121 942 | -52.6% | 13.4% | -9.8 | 183 826 345 | -45.5% | 15.3% | -9.4 | -18.0% |
| RESPERO MYRTOL | 138 537 | -43.1% | 7.2% | -3 | 79 298 050 | -25.9% | 8.4% | -1.4 | -19.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 280 696 | -43.2% | 4.3% | -2.3 | 1 777 112 518 | -30.5% | 4.3% | -1.7 | -12.9% |
| DEXALGIN | 1 422 818 | -25.5% | 0.6% | -0.1 | 639 187 720 | -12.5% | 1.6% | -0.4 | -5.6% |
| ESPUMISAN (ADULTS) | 3 921 211 | -26.5% | 50.5% | -14.6 | 2 088 607 382 | -15.7% | 56.7% | -13.2 | -5.3% |
| ESPUMISAN BABY | 1 349 362 | -18.1% | 35.8% | -5.1 | 884 244 799 | -8.4% | 49.5% | -6.1 | -6.3% |
| FASTUM | 955 883 | -30.9% | 1.0% | -0.4 | 519 793 557 | -19.1% | 2.4% | -0.7 | -2.6% |
| IODOMARIN | 3 202 865 | -2.8% | 20.4% | -0.7 | 624 189 623 | 2.0% | 8.9% | -0.6 | 0.6% |
| LIOTON | 1 175 164 | -30.6% | 2.1% | -0.6 | 1 272 024 499 | -10.4% | 4.5% | -1.1 | -9.8% |
| MEZYM | 15 735 161 | -26.3% | 24.0% | -5.5 | 2 433 933 092 | -18.9% | 17.0% | -5.1 | -9.3% |
| MIG 400 | 7 863 698 | -23.5% | 3.1% | -0.7 | 940 482 545 | -19.2% | 2.3% | -0.8 | -5.6% |
| PROSTAMOL | 1 411 291 | -33.4% | 16.9% | -7.4 | 2 011 338 453 | -25.4% | 18.2% | -8.1 | -4.3% |
| RESPERO MYRTOL | 1 196 419 | 23.6% | 7.9% | 1.6 | 595 904 283 | 35.2% | 8.3% | 1.8 | -1.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 99 622 | -4.3% | 2.8% | 0.1 | 27 394 018 | -4.2% | 3.4% | 0.1 | -6.7% |
| DEXALGIN | 14 445 | -8.2% | 0.3% | 0 | 7 974 846 | -5.6% | 1.1% | 0 | -5.9% |
| ESPUMISAN (ADULTS) | 49 235 | -3.2% | 38.6% | 0 | 31 401 775 | -3.1% | 48.7% | 0.4 | -3.2% |
| ESPUMISAN BABY | 19 726 | -4.5% | 30.0% | 0.1 | 15 520 372 | -3.6% | 47.7% | 0.5 | -4.9% |
| FASTUM | 12 905 | -5.0% | 0.8% | 0 | 7 867 163 | -3.5% | 2.2% | 0 | -4.0% |
| IODOMARIN | 64 655 | -2.1% | 22.3% | -0.2 | 12 122 775 | -1.5% | 9.0% | -0.2 | -1.3% |
| LIOTON | 15 499 | -15.7% | 1.8% | -0.3 | 19 438 048 | -15.7% | 4.7% | -0.6 | -3.1% |
| MEZYM | 189 325 | -4.3% | 19.1% | 0 | 30 087 867 | -3.6% | 13.0% | -0.1 | -4.3% |
| MIG 400 | 91 671 | -6.0% | 2.1% | 0 | 11 257 964 | -5.1% | 1.6% | 0 | -5.9% |
| PROSTAMOL | 18 749 | -4.5% | 12.4% | -0.2 | 28 674 527 | -3.8% | 14.1% | -0.3 | -3.2% |
| RESPERO MYRTOL | 22 256 | -7.6% | 6.8% | -0.5 | 13 024 566 | -6.9% | 8.2% | -0.6 | -1.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| DEXALGIN | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| ESPUMISAN (ADULTS) | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| ESPUMISAN BABY | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| FASTUM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| IODOMARIN | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| LIOTON | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| MEZYM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| MIG 400 | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| PROSTAMOL | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| RESPERO MYRTOL | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs